Recombinant Antibodies for Immunotherapy [ electronic resource ] / edited by Melvyn Little.
Contributor(s): Little, Melvyn [editor].
Material type:
TextPublisher: Cambridge: Cambridge University Press , 2009ISBN: 9780511596773 ( e-book ).Subject(s): Biotechnology | Microbiology and Immunology | Life SciencesGenre/Form: Electronic booksDDC classification: 615.37 Online resources: https://doi.org/10.1017/CBO9780511596773 View to click Summary: Recombinant Antibodies for Immunotherapy provides a comprehensive overview of the field of monoclonal antibodies (mAbs), a market that has grown tremendously in recent years. Twenty-five articles by experienced and innovative authors cover the isolation of specific human mAbs, humanization, immunogenicity, technologies for improving efficacy, 'arming' mAbs, novel alternative Ab constructs, increasing half-lives, alternative concepts employing non-immunoglobulin scaffolds, novel therapeutic approaches, a market analysis of therapeutic mAbs, and future developments in the field. The concepts and technologies are illustrated by examples of recombinant antibodies being used in the clinic or in development. This book will appeal to both newcomers and experienced scientists in the field, biology and biotechnology students, research and development departments in the pharmaceutical industry, medical researchers, clinicians, and biotechnology investors.
| Item type | Current location | Call number | Status | Date due | Barcode |
|---|---|---|---|---|---|
E-Book
|
WWW | 615.37 LIT/R (Browse shelf) | Available | EB97 |
Recombinant Antibodies for Immunotherapy provides a comprehensive overview of the field of monoclonal antibodies (mAbs), a market that has grown tremendously in recent years. Twenty-five articles by experienced and innovative authors cover the isolation of specific human mAbs, humanization, immunogenicity, technologies for improving efficacy, 'arming' mAbs, novel alternative Ab constructs, increasing half-lives, alternative concepts employing non-immunoglobulin scaffolds, novel therapeutic approaches, a market analysis of therapeutic mAbs, and future developments in the field. The concepts and technologies are illustrated by examples of recombinant antibodies being used in the clinic or in development. This book will appeal to both newcomers and experienced scientists in the field, biology and biotechnology students, research and development departments in the pharmaceutical industry, medical researchers, clinicians, and biotechnology investors.
There are no comments for this item.